SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-296896
Filing Date
2020-11-18
Accepted
2020-11-18 15:35:52
Documents
1
Group Members
ALAN FRAZIERBRIAN MORFITTFHM V, L.L.C.FHM V, L.P.FHM VII, L.L.C.FHM VII, L.P.FRAZIER HEALTHCARE VII, L.P.FRAZIER HEALTHCARE VII-A, L.P.JAMES N. TOPPERNADER NAININATHAN EVERYPATRICK J. HERON

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D d833571dsc13da.htm SC 13D/A 219938
  Complete submission text file 0001193125-20-296896.txt   221998
Mailing Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 (206) 621-7200
Frazier Healthcare V, LP (Filed by) CIK: 0001341169 (see all company filings)

IRS No.: 830410164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Subject) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89797 | Film No.: 201324759
SIC: 2834 Pharmaceutical Preparations